Fig. 63
From: Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
68Ga-DOTA peptide, recurrent medullary thyroid cancer (MTC). Clinical history: 56 y.o. man with previous history of MTC, treated by surgery. Progressive increase in calcitonin (TCT = 19200). PET/CT findings: increased uptake in cervical LN (a) and bone lesion (b right scapula). Additional hepatic metastases are seen on the diagnostic CT, but due to the high background they are not evident on PET images (c)